These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 36278424)
21. Recent advances in diagnostic and therapeutic guidelines for primary and secondary hemophagocytic lymphohistiocytosis. Ramachandran S; Zaidi F; Aggarwal A; Gera R Blood Cells Mol Dis; 2017 May; 64():53-57. PubMed ID: 28433836 [TBL] [Abstract][Full Text] [Related]
22. [Hemophagocytic lymphohistiocytosis--a contemporary medical problem]. Machaczka M Pol Merkur Lekarski; 2012 Jan; 32(187):59-63. PubMed ID: 22400183 [TBL] [Abstract][Full Text] [Related]
23. Hemophagocytic lymphohistiocytosis: A disorder of T cell activation, immune regulation, and distinctive immunopathology. Jordan MB Immunol Rev; 2024 Mar; 322(1):339-350. PubMed ID: 38100247 [TBL] [Abstract][Full Text] [Related]
24. The hyperinflammatory spectrum: from defects in cytotoxicity to cytokine control. Planas R; Felber M; Vavassori S; Pachlopnik Schmid J Front Immunol; 2023; 14():1163316. PubMed ID: 37187762 [TBL] [Abstract][Full Text] [Related]
25. Therapeutic effect of JAK1/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice. Maschalidi S; Sepulveda FE; Garrigue A; Fischer A; de Saint Basile G Blood; 2016 Jul; 128(1):60-71. PubMed ID: 27222478 [TBL] [Abstract][Full Text] [Related]
26. [Hemophagocytic lymphohistiocytosis: diagnostic problems in pediatrics]. Balwierz W; Czogała M; Pawińska-Wasikowska K; Cwiklińska M; Walicka-Soja K Przegl Lek; 2010; 67(6):417-24. PubMed ID: 21344773 [TBL] [Abstract][Full Text] [Related]
27. [Heterogeneity of HLH pathophysiology and treatment strategies]. Yasumi T; Shibata H; Shimodera S; Heike T Rinsho Ketsueki; 2015 Oct; 56(10):2248-57. PubMed ID: 26458466 [TBL] [Abstract][Full Text] [Related]
35. Graded defects in cytotoxicity determine severity of hemophagocytic lymphohistiocytosis in humans and mice. Jessen B; Kögl T; Sepulveda FE; de Saint Basile G; Aichele P; Ehl S Front Immunol; 2013; 4():448. PubMed ID: 24379813 [TBL] [Abstract][Full Text] [Related]
36. The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2. Jessen B; Bode SF; Ammann S; Chakravorty S; Davies G; Diestelhorst J; Frei-Jones M; Gahl WA; Gochuico BR; Griese M; Griffiths G; Janka G; Klein C; Kögl T; Kurnik K; Lehmberg K; Maul-Pavicic A; Mumford AD; Pace D; Parvaneh N; Rezaei N; de Saint Basile G; Schmitt-Graeff A; Schwarz K; Karasu GT; Zieger B; Zur Stadt U; Aichele P; Ehl S Blood; 2013 Apr; 121(15):2943-51. PubMed ID: 23403622 [TBL] [Abstract][Full Text] [Related]
38. Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis. Johnson TS; Terrell CE; Millen SH; Katz JD; Hildeman DA; Jordan MB J Immunol; 2014 Jan; 192(1):84-91. PubMed ID: 24259502 [TBL] [Abstract][Full Text] [Related]
39. Disturbances in NK Cells in Various Types of Hemophagocytic Lymphohistiocytosis in a Population of Polish Children. Popko K; Górska E; Wołowiec M; Malinowska I J Pediatr Hematol Oncol; 2019 Jul; 41(5):e277-e283. PubMed ID: 31107368 [TBL] [Abstract][Full Text] [Related]
40. [Precise diagnosis and treatment of hemophagocytic lymphohistiocytosis guided by cytokine patterns]. Xu XJ; Tang YM Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2142-2147. PubMed ID: 35872577 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]